Evidence map›Paper›PMID 36502401›Full record

ReviewEmerging infectious diseases2022

Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa.

Danica J Gomes, Carmen Hazim, Jacqueline Safstrom, Carolyn Herzig, Ulzii Luvsansharav, Cori Dennison, Yakob Ahmed, Evelyn Wesangula, Joseph Hokororo, Jackson Amone and 13 more

Open access · diamondAbstract readReview
In one paragraph

Review in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Global Responses to the COVID-19 PandemicEmerging infectious diseases · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Danica J Gomes
Carmen Hazim
Jacqueline Safstrom
Carolyn Herzig
Ulzii Luvsansharav
Cori Dennison
Yakob Ahmed
Evelyn Wesangula
Joseph Hokororo
Jackson Amone
Berhanu Tekle
George Owiso
Rita Mutayoba
Mohammed Lamorde
Evelyn Akello
Getachew Kassa
Beniam Feleke
Linus Ndegwa
Kokuhumbya Kazaura
Diriisa Musisi
Anand Date
Benjamin J Park
Elizabeth Bancroft

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease pandemic has highlighted the need to establish and maintain strong infection prevention and control (IPC) practices, not only to prevent healthcare-associated transmission of SARS-CoV-2 to healthcare workers and patients but also to prevent disruptions of essential healthcare services. In East Africa, where basic IPC capacity in healthcare facilities is limited, the US Centers for Disease Control and Prevention (CDC) supported rapid IPC capacity building in healthcare facilities in 4 target countries: Tanzania, Ethiopia, Kenya, and Uganda. CDC supported IPC capacity-building initiatives at the healthcare facility and national levels according to each country's specific needs, priorities, available resources, and existing IPC capacity and systems. In addition, CDC established a multicountry learning network to strengthen hospital level IPC, with an emphasis on peer-to-peer learning. We present an overview of the key strategies used to strengthen IPC in these countries and lessons learned from implementation.

Indexed as

COVID-19SARS-CoV-2Delivery of Health CareHealth FacilitiesHumansInfection ControlPandemicscapacity buildingcoronavirus diseasecoronavirusesCOVID-19East Africaessential healthcare servicesEthiopiahealthcare-associated transmissionhealthcare facilitieshealthcare workersinfection prevention and control initiativesKenyalow-income countriesmiddle-income countriesrespiratory infectionsSARS-CoV-2severe acute respiratory syndrome coronavirus 2TanzaniaUgandaviruseszoonoses

Identifiers

PMID36502401
PMCPMC9745220
OpenAlexW4312066259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.